Andrew Bryant
Jan Lecouturier
Giovany Orozco Leal
Dr Vicky Brocklebank
Dr Sonya Carnell
et al. | Clinical and cost-effectiveness of eculizumab withdrawal in atypical haemolytic uraemic syndrome: the SETS aHUS multi-centre, open-label, prospective and single-arm study | 2026 |
|
Professor Luke Vale
| Barriers and Determinants of Referral Adherence in AI-Enabled Diabetic Retinopathy Screening for Older Adults in Northern India During the COVID-19 Pandemic: Mixed Methods Pilot Study | 2025 |
|
Salamatu Abdul-Aziz
Dr Nawaraj Bhattarai
Professor Luke Vale
Dr Gurdeep Sagoo
Dr Asima Mukhopadhyay
| Challenges and opportunities to address the emerging burden of targeted therapies in ovarian cancer | 2025 |
|
Helen Mossop
Sarah Al-Ashmori
Tumi Sotire
Dr Emma Clark
Gillian Watson
et al. | Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension (CONFORM-OH): results from an internal pilot randomised controlled trial | 2025 |
|
Emerita Professor Jacqueline Rodgers
Mirabel Pelton
Dr Jane Goodwin
Dr Nawaraj Bhattarai
Professor Colin Wilson
et al. | Corrigendum to “Feasibility and acceptability of Autism Adapted Safety Plans: an external pilot randomised controlled trial” | 2025 |
|
Susan Lennie
Professor Luke Vale
Emerita Professor Dawn Teare
Raya Vinogradov
Professor Nicola Heslehurst
| Exploring Pregnant Women’s Perceptions and Experiences ofAdiposity Measurements in Routine Antenatal Care:A Qualitative Study | 2025 |
|
Dr Nawaraj Bhattarai
Dr Jane Goodwin
Mirabel Pelton
Isabel Gordon
Emerita Professor Jacqueline Rodgers
et al. | Health economic evaluation of Autism Adapted Safety Plans: findings on feasibility of tools from a pilot randomised controlled trial. | 2025 |
|
Eugenie Johnson
Giovany Orozco Leal
Madeleine Still
Nicole O'Connor
Dr Lakshmi Jayachandran
et al. | Methods used in Early Value Assessments for NICE: a scoping review | 2025 |
|
Dr Matt Breckons
Professor Luke Vale
Dr Lorraine McSweeney
Professor Quentin Anstee
| NASH-CHECK patient-reported outcome instrument: evaluation of content and face validity for patients with metabolic dysfunction–associated steatohepatitis and compensated cirrhosis | 2025 |
|
Susan Lennie
Dr Gina Nguyen
Dr Anna Boath
Professor Luke Vale
Professor Dawn Teare
et al. | Subjective Evaluation of Female Adult Body Fat Distribution: A Scoping Review | 2025 |
|
Dr Ian Forrest
Professor John Simpson
Professor Luke Vale
Shajahan Wahed
Professor Christopher Ward
| The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial | 2025 |
|
Dr Victoria Grahame
Dr Ashleigh Kernohan
Ayesha Mathias
Chrissie Butcher
Deborah Garland
et al. | Understanding Repetitive Behaviours: A clinical and cost-effectiveness, multi-site randomised controlled trial of a group for parents and carers of young autistic children | 2025 |
|
Will King
Tara Homer
Professor Christopher Harding
Helen Mossop
Dr Thomas Chadwick
et al. | Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial | 2024 |
|
Professor Andrew Fisher
Professor Helen Hancock
Professor James Wason
Dr Michael Grayling
Dr Joanne Lally
et al. | Extracorporeal Photopheresis (ECP) in the Treatment of Chronic Lung Allograft Dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK) | 2024 |
|
Emerita Professor Jacqueline Rodgers
Mirabel Pelton
Dr Jane Goodwin
Isabel Gordon
Professor Luke Vale
| Feasibility and acceptability of autism adapted safety plans: an external pilot randomised controlled trial | 2024 |
|
